For more than 20 years, researchers have benefitted from DNA, RNA, and protein analysis of various sample types using the 2100 Bioanalyzer instrument in many workflows.

Since December 31, 2023, the 2100 Bioanalyzer instrument is no longer available for purchase. Bioanalyzer kits and reagents, including support for instruments, consumables, and software, will continue to be available until 2030. This also includes our established repair, preventive maintenance, and qualification services. With expertise in DNA, RNA, and protein QC, Agilent has developed advanced technologies such as the TapeStation, Fragment Analyzer, and ProteoAnalyzer systems, providing additional features and compelling benefits for your QC workflow needs.